Your session is about to expire
← Back to Search
Behavioral Intervention
Music Training for Cochlear Implant Users (MACI Trial)
N/A
Recruiting
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Teenage and adult cochlear implant users
Must not have
Children younger than 13
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measure collected at 0, 4, and 8 week mark to examine change in discrimination thresholds.
Awards & highlights
No Placebo-Only Group
Summary
This trial will study how people who have gotten cochlear implants react to music. It will help researchers understand how music appreciation works and what role it plays in quality of life.
Who is the study for?
This trial is for teenagers and adults who use cochlear implants due to hearing loss. It's not open to children under the age of 13.
What is being tested?
The study focuses on how people with cochlear implants start to appreciate music again. Participants will undergo musical pitch training to see if it helps improve their enjoyment and understanding of music.
What are the potential side effects?
Since this trial involves non-invasive musical training, there are no direct medical side effects expected from participating.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I use a cochlear implant.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am under 13 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measure collected at 0, 4, and 8 week mark to examine change in speech recognition thresholds.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measure collected at 0, 4, and 8 week mark to examine change in speech recognition thresholds.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Pitch Discrimination measured using Psychophysical Procedures
Secondary study objectives
Change in Speech Recognition Thresholds measured using Psychophysical Procedures
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: AuditoryExperimental Treatment1 Intervention
Group receives training on listening to musical pitch differences between sounds as the first component of a crossover trial. The intervention is the listening exercises. Exercises are completed daily as 30-minute sessions for 4 weeks. Hearing assessment outcomes of speech comprehension in background noise and of musical pitch sensitivity are conducted at baseline and at midpoint and endpoint.
Group II: VisualActive Control1 Intervention
Group receives training on visual differences between objects on a computer screen as the first component of a crossover trial. This is a control measure for the auditory training exercises. Exercises are completed daily as 30-minute sessions for 4 weeks. Hearing assessment outcomes of speech comprehension in background noise and of musical pitch sensitivity are conducted at baseline and at midpoint and endpoint.
Find a Location
Who is running the clinical trial?
University of California, MercedOTHER
17 Previous Clinical Trials
6,001 Total Patients Enrolled
University of Southern CaliforniaLead Sponsor
944 Previous Clinical Trials
1,604,525 Total Patients Enrolled
8 Trials studying Hearing Loss
1,186 Patients Enrolled for Hearing Loss
Ohio State UniversityOTHER
866 Previous Clinical Trials
655,004 Total Patients Enrolled
6 Trials studying Hearing Loss
226 Patients Enrolled for Hearing Loss
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I use a cochlear implant.I am under 13 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Visual
- Group 2: Auditory
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger